FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040304087> ?p ?o ?g. }

• W3040304087 endingPage "1385" @default.
• W3040304087 startingPage "1376" @default.
• W3040304087 abstract "Concurrent chemoradiation is standard-of-care for patients with squamous cell carcinoma of the anus. Poor compliance to chemotherapy, radiotherapy treatment interruptions and unplanned breaks may impact adversely on long-term outcomes.The ACT II trial recruited 940 patients with localised squamous cell carcinoma of the anus, and assigned patients to mitomycin (week 1) or cisplatin (weeks 1 and 5), with fluorouracil (weeks 1 and 5) and radiotherapy (50.4 Gy in 28 fractions over 38 days). This post hoc analysis examined the association between baseline factors (age, gender, site, T stage and N stage), and compliance to treatment (radiotherapy and chemotherapy), and their effects on locoregional failure-free survival, progression-free survival (PFS) and overall survival (OS). Compliance was categorised into groups. Radiotherapy: six groups according to total dose and overall treatment time (OTT). Chemotherapy: three groups (A = per-protocol; B = dose reduction or delay; C = omitted).A total of 931/940 patients were assessable for radiotherapy and 936 for chemotherapy compliance. Baseline glomerular filtration rate <60 ml/min and cisplatin were significantly associated with poor week 5 compliance to chemotherapy (P = 0.003 and 0.02, respectively). Omission of week 5 chemotherapy was associated with significantly worse locoregional failure-free survival [hazard ratio (HR) 2.53 (1.33-4.82) P = 0.005]. Dose reductions/delays or omission of week 5 chemotherapy were associated with significantly worse PFS {HR: 1.56 [95% confidence interval (CI): 1.18-2.06], P = 0.002 and HR: 2.39 (95% CI: 1.44-3.98), P = 0.001, respectively} and OS [HR: 1.92 (95% CI: 1.41-2.63), P < 0.001 and HR: 2.88 (95% CI: 1.63-5.08), P < 0.001, respectively]. Receiving the target radiotherapy dose in >42 days is associated with worse PFS and OS [HR: 1.72 (95% CI: 1.17-2.54), P =0.006].Poor compliance to chemotherapy and radiotherapy were associated with worse locoregional failure-free survival, PFS and OS. Treatment interruptions should be minimised, and OTT and total dose maintained.ISRCTN 26715889." @default.
• W3040304087 created "2020-07-10" @default.
• W3040304087 creator A5015912702 @default.
• W3040304087 creator A5017956085 @default.
• W3040304087 creator A5035078656 @default.
• W3040304087 creator A5045813553 @default.
• W3040304087 creator A5048443554 @default.
• W3040304087 creator A5050553727 @default.
• W3040304087 date "2020-10-01" @default.
• W3040304087 modified "2023-09-23" @default.
• W3040304087 title "Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial" @default.
• W3040304087 cites W1804130247 @default.
• W3040304087 cites W1947979503 @default.
• W3040304087 cites W2002002528 @default.
• W3040304087 cites W2016597272 @default.
• W3040304087 cites W2024765799 @default.
• W3040304087 cites W2029919879 @default.
• W3040304087 cites W2032111846 @default.
• W3040304087 cites W2055442814 @default.
• W3040304087 cites W2066861752 @default.
• W3040304087 cites W2070954146 @default.
• W3040304087 cites W2076341925 @default.
• W3040304087 cites W2124675713 @default.
• W3040304087 cites W2129300711 @default.
• W3040304087 cites W2140574556 @default.
• W3040304087 cites W2164644812 @default.
• W3040304087 cites W2197869810 @default.
• W3040304087 cites W2547143317 @default.
• W3040304087 cites W2589045288 @default.
• W3040304087 cites W2662946175 @default.
• W3040304087 cites W2897964092 @default.
• W3040304087 cites W2981075438 @default.
• W3040304087 cites W3010769284 @default.
• W3040304087 cites W776995397 @default.
• W3040304087 doi "https://doi.org/10.1016/j.annonc.2020.06.012" @default.
• W3040304087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32619648" @default.
• W3040304087 hasPublicationYear "2020" @default.
• W3040304087 type Work @default.
• W3040304087 sameAs 3040304087 @default.
• W3040304087 citedByCount "22" @default.
• W3040304087 countsByYear W30403040872020 @default.
• W3040304087 countsByYear W30403040872021 @default.
• W3040304087 countsByYear W30403040872022 @default.
• W3040304087 countsByYear W30403040872023 @default.
• W3040304087 crossrefType "journal-article" @default.
• W3040304087 hasAuthorship W3040304087A5015912702 @default.
• W3040304087 hasAuthorship W3040304087A5017956085 @default.
• W3040304087 hasAuthorship W3040304087A5035078656 @default.
• W3040304087 hasAuthorship W3040304087A5045813553 @default.
• W3040304087 hasAuthorship W3040304087A5048443554 @default.
• W3040304087 hasAuthorship W3040304087A5050553727 @default.
• W3040304087 hasBestOaLocation W30403040871 @default.
• W3040304087 hasConcept C121608353 @default.
• W3040304087 hasConcept C126322002 @default.
• W3040304087 hasConcept C126894567 @default.
• W3040304087 hasConcept C141071460 @default.
• W3040304087 hasConcept C143998085 @default.
• W3040304087 hasConcept C207103383 @default.
• W3040304087 hasConcept C2776694085 @default.
• W3040304087 hasConcept C2778424827 @default.
• W3040304087 hasConcept C2779840525 @default.
• W3040304087 hasConcept C2779973185 @default.
• W3040304087 hasConcept C44249647 @default.
• W3040304087 hasConcept C509974204 @default.
• W3040304087 hasConcept C67761136 @default.
• W3040304087 hasConcept C71924100 @default.
• W3040304087 hasConceptScore W3040304087C121608353 @default.
• W3040304087 hasConceptScore W3040304087C126322002 @default.
• W3040304087 hasConceptScore W3040304087C126894567 @default.
• W3040304087 hasConceptScore W3040304087C141071460 @default.
• W3040304087 hasConceptScore W3040304087C143998085 @default.
• W3040304087 hasConceptScore W3040304087C207103383 @default.
• W3040304087 hasConceptScore W3040304087C2776694085 @default.
• W3040304087 hasConceptScore W3040304087C2778424827 @default.
• W3040304087 hasConceptScore W3040304087C2779840525 @default.
• W3040304087 hasConceptScore W3040304087C2779973185 @default.
• W3040304087 hasConceptScore W3040304087C44249647 @default.
• W3040304087 hasConceptScore W3040304087C509974204 @default.
• W3040304087 hasConceptScore W3040304087C67761136 @default.
• W3040304087 hasConceptScore W3040304087C71924100 @default.
• W3040304087 hasFunder F4320319985 @default.
• W3040304087 hasIssue "10" @default.
• W3040304087 hasLocation W30403040871 @default.
• W3040304087 hasLocation W30403040872 @default.
• W3040304087 hasLocation W30403040873 @default.
• W3040304087 hasOpenAccess W3040304087 @default.
• W3040304087 hasPrimaryLocation W30403040871 @default.
• W3040304087 hasRelatedWork W2105203627 @default.
• W3040304087 hasRelatedWork W2114624491 @default.
• W3040304087 hasRelatedWork W2194631636 @default.
• W3040304087 hasRelatedWork W2390408846 @default.
• W3040304087 hasRelatedWork W2404042595 @default.
• W3040304087 hasRelatedWork W2613320295 @default.
• W3040304087 hasRelatedWork W3134551233 @default.
• W3040304087 hasRelatedWork W4245694863 @default.
• W3040304087 hasRelatedWork W4308718010 @default.
• W3040304087 hasRelatedWork W2118673085 @default.
• W3040304087 hasVolume "31" @default.

• next